Advocacy Actions
Met with CAFFCI President to address industrial concerns
Met with CAFFCI President to address industrial concerns
Read moreHCE Working Group Provides Feedback on Proposed Lithium-Ion Battery Standards for Portable Medical Devices
The HCE Working Group provided feedback on MIIT's proposals for safety and general specifications for lithium-ion cells and batteries in portable medical devices. They sought clarification on compliance for manufacturers sourcing batteries externally and requested detail on standard requirements for manufacturers and suppliers. They also suggested aligning the proposed standard with existing ones like IEC62620 and recommended revising ambiguous text for clarity.
Read moreSubmission of feedback on cross-border data transfer barriers as experienced by different industries and sectors
On 29th February the European Chamber submitted feedback on how different industries are affected by the current Chinese regulatory landscape on cross-border data transfer.
Read moreMet with Invest Shanghai Director Xue Feng
On 28th February, Shanghai Chapter General Manager met with Invest Shanghai Director Xue Feng and European Department colleague.
Read moreHeld Concall with European Federation of Pharmaceutical Industries and Associations (EFPIA)
On 28th February, European Chamber held a concall with the European Federation of Pharmaceutical Industries and Associations (EFPIA) to discuss the potential collaboration projects in 2024.
Read moreCosmetic Experts meeting with SH MPA on full safety assessment implementation
Participated the industrial roundtable discussion on full safety assessment with presence of NMPA DG LI Jinju and SH MPA DDG ZHAO Yanjun.
Read moreSent the chamber proposal to SH MPA as the follow-up action on full safety assessment
Sent the chamber proposal to SH MPA as the follow-up action on full safety assessment
Read morePhamaceutical WG sent comments to National Healthcare Security Administration
On 26th February, European Chamber Pharmaceutical Working Group sent comments to the National Healthcare Security Administration (NHSA) regarding the Draft Notice on the Launch Price Setting Mechanism for Newly Listed Chemical Drugs
and on the Encouragement of High-Quality Innovation (Draft for comments).
Pharma WG held concall with EFPIA core team on 2024 EU-China Pharma Regulatory Roundtable
On 26th February, European Chamber Pharmaceutical Working Group held an online concall with the core team of the European Federation for Pharmaceutical Industries and Associations (EFPIA) to discuss the preparation for the 2024 EU-China Pharmaceutical Regulatory Roundtable.
Read moreSent the chamber draft reports for the three testing to SH MPA as the follow-up action on full safety assessment
Sent the chamber draft reports for the three testing to SH MPA as the follow-up action on full safety assessment.
Read more